| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 | 
| NetGPI | no | yes: 0, no: 11 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 9 | 
| GO:0110165 | cellular anatomical entity | 1 | 9 | 
| GO:0016020 | membrane | 2 | 1 | 
Related structures:
AlphaFold database: A0A3Q8IAU3
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006807 | nitrogen compound metabolic process | 2 | 12 | 
| GO:0008152 | metabolic process | 1 | 12 | 
| GO:0009056 | catabolic process | 2 | 12 | 
| GO:0009057 | macromolecule catabolic process | 4 | 12 | 
| GO:0019538 | protein metabolic process | 3 | 12 | 
| GO:0030163 | protein catabolic process | 4 | 12 | 
| GO:0043170 | macromolecule metabolic process | 3 | 12 | 
| GO:0044238 | primary metabolic process | 2 | 12 | 
| GO:0071704 | organic substance metabolic process | 2 | 12 | 
| GO:1901564 | organonitrogen compound metabolic process | 3 | 12 | 
| GO:1901565 | organonitrogen compound catabolic process | 4 | 12 | 
| GO:1901575 | organic substance catabolic process | 3 | 12 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 12 | 
| GO:0008914 | leucyltransferase activity | 4 | 12 | 
| GO:0016740 | transferase activity | 2 | 12 | 
| GO:0016746 | acyltransferase activity | 3 | 12 | 
| GO:0016755 | aminoacyltransferase activity | 3 | 12 | 
| GO:0140096 | catalytic activity, acting on a protein | 2 | 12 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 85 | 89 | PF00656 | 0.471 | 
| CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.581 | 
| CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.411 | 
| CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.436 | 
| CLV_NRD_NRD_1 | 307 | 309 | PF00675 | 0.465 | 
| CLV_NRD_NRD_1 | 318 | 320 | PF00675 | 0.430 | 
| CLV_NRD_NRD_1 | 371 | 373 | PF00675 | 0.570 | 
| CLV_NRD_NRD_1 | 377 | 379 | PF00675 | 0.571 | 
| CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.496 | 
| CLV_PCSK_KEX2_1 | 318 | 320 | PF00082 | 0.478 | 
| CLV_PCSK_KEX2_1 | 362 | 364 | PF00082 | 0.621 | 
| CLV_PCSK_KEX2_1 | 376 | 378 | PF00082 | 0.534 | 
| CLV_PCSK_PC1ET2_1 | 362 | 364 | PF00082 | 0.630 | 
| CLV_PCSK_PC7_1 | 372 | 378 | PF00082 | 0.493 | 
| CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.486 | 
| CLV_PCSK_SKI1_1 | 212 | 216 | PF00082 | 0.496 | 
| CLV_PCSK_SKI1_1 | 362 | 366 | PF00082 | 0.636 | 
| CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.346 | 
| DEG_APCC_DBOX_1 | 199 | 207 | PF00400 | 0.394 | 
| DOC_CDC14_PxL_1 | 107 | 115 | PF14671 | 0.385 | 
| DOC_CYCLIN_yCln2_LP_2 | 195 | 201 | PF00134 | 0.431 | 
| DOC_MAPK_gen_1 | 175 | 182 | PF00069 | 0.463 | 
| DOC_MAPK_gen_1 | 223 | 232 | PF00069 | 0.509 | 
| DOC_MAPK_gen_1 | 296 | 306 | PF00069 | 0.476 | 
| DOC_MAPK_gen_1 | 372 | 381 | PF00069 | 0.512 | 
| DOC_MAPK_gen_1 | 69 | 78 | PF00069 | 0.570 | 
| DOC_MAPK_MEF2A_6 | 93 | 102 | PF00069 | 0.417 | 
| DOC_PP2B_LxvP_1 | 108 | 111 | PF13499 | 0.439 | 
| DOC_PP2B_LxvP_1 | 195 | 198 | PF13499 | 0.473 | 
| DOC_PP4_FxxP_1 | 207 | 210 | PF00568 | 0.444 | 
| DOC_PP4_FxxP_1 | 53 | 56 | PF00568 | 0.470 | 
| DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.553 | 
| DOC_USP7_MATH_1 | 317 | 321 | PF00917 | 0.429 | 
| DOC_USP7_MATH_1 | 56 | 60 | PF00917 | 0.505 | 
| DOC_USP7_UBL2_3 | 212 | 216 | PF12436 | 0.488 | 
| DOC_USP7_UBL2_3 | 309 | 313 | PF12436 | 0.386 | 
| DOC_USP7_UBL2_3 | 357 | 361 | PF12436 | 0.633 | 
| DOC_USP7_UBL2_3 | 362 | 366 | PF12436 | 0.590 | 
| DOC_WW_Pin1_4 | 233 | 238 | PF00397 | 0.598 | 
| DOC_WW_Pin1_4 | 76 | 81 | PF00397 | 0.394 | 
| LIG_14-3-3_CanoR_1 | 129 | 133 | PF00244 | 0.413 | 
| LIG_14-3-3_CanoR_1 | 296 | 302 | PF00244 | 0.523 | 
| LIG_BRCT_BRCA1_1 | 105 | 109 | PF00533 | 0.241 | 
| LIG_BRCT_BRCA1_1 | 78 | 82 | PF00533 | 0.366 | 
| LIG_CaM_IQ_9 | 3 | 19 | PF13499 | 0.512 | 
| LIG_FHA_1 | 213 | 219 | PF00498 | 0.355 | 
| LIG_FHA_2 | 63 | 69 | PF00498 | 0.471 | 
| LIG_LIR_Apic_2 | 51 | 56 | PF02991 | 0.482 | 
| LIG_LIR_Gen_1 | 168 | 173 | PF02991 | 0.394 | 
| LIG_LIR_Nem_3 | 168 | 172 | PF02991 | 0.390 | 
| LIG_LIR_Nem_3 | 181 | 186 | PF02991 | 0.358 | 
| LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.409 | 
| LIG_PDZ_Class_2 | 376 | 381 | PF00595 | 0.531 | 
| LIG_Pex14_2 | 78 | 82 | PF04695 | 0.382 | 
| LIG_SH2_CRK | 227 | 231 | PF00017 | 0.477 | 
| LIG_SH2_GRB2like | 227 | 230 | PF00017 | 0.514 | 
| LIG_SH2_NCK_1 | 227 | 231 | PF00017 | 0.477 | 
| LIG_SH2_NCK_1 | 257 | 261 | PF00017 | 0.383 | 
| LIG_SH2_STAP1 | 213 | 217 | PF00017 | 0.440 | 
| LIG_SH2_STAT5 | 251 | 254 | PF00017 | 0.362 | 
| LIG_SH2_STAT5 | 264 | 267 | PF00017 | 0.318 | 
| LIG_SH2_STAT5 | 329 | 332 | PF00017 | 0.492 | 
| LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.477 | 
| LIG_SH3_3 | 301 | 307 | PF00018 | 0.404 | 
| LIG_SUMO_SIM_par_1 | 177 | 184 | PF11976 | 0.508 | 
| LIG_UBA3_1 | 326 | 335 | PF00899 | 0.565 | 
| LIG_WRC_WIRS_1 | 50 | 55 | PF05994 | 0.513 | 
| MOD_CK1_1 | 233 | 239 | PF00069 | 0.566 | 
| MOD_CK2_1 | 62 | 68 | PF00069 | 0.444 | 
| MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.525 | 
| MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.366 | 
| MOD_GlcNHglycan | 266 | 269 | PF01048 | 0.349 | 
| MOD_GlcNHglycan | 282 | 285 | PF01048 | 0.382 | 
| MOD_GlcNHglycan | 315 | 318 | PF01048 | 0.520 | 
| MOD_GSK3_1 | 150 | 157 | PF00069 | 0.493 | 
| MOD_GSK3_1 | 161 | 168 | PF00069 | 0.398 | 
| MOD_GSK3_1 | 208 | 215 | PF00069 | 0.523 | 
| MOD_GSK3_1 | 264 | 271 | PF00069 | 0.379 | 
| MOD_GSK3_1 | 313 | 320 | PF00069 | 0.468 | 
| MOD_N-GLC_1 | 160 | 165 | PF02516 | 0.518 | 
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.496 | 
| MOD_NEK2_1 | 150 | 155 | PF00069 | 0.453 | 
| MOD_NEK2_1 | 272 | 277 | PF00069 | 0.419 | 
| MOD_PIKK_1 | 355 | 361 | PF00454 | 0.685 | 
| MOD_PKA_1 | 154 | 160 | PF00069 | 0.543 | 
| MOD_PKA_2 | 128 | 134 | PF00069 | 0.519 | 
| MOD_PKA_2 | 317 | 323 | PF00069 | 0.533 | 
| MOD_PKA_2 | 7 | 13 | PF00069 | 0.479 | 
| MOD_PKB_1 | 223 | 231 | PF00069 | 0.493 | 
| MOD_Plk_1 | 103 | 109 | PF00069 | 0.260 | 
| MOD_Plk_2-3 | 62 | 68 | PF00069 | 0.498 | 
| MOD_Plk_4 | 1 | 7 | PF00069 | 0.555 | 
| MOD_Plk_4 | 103 | 109 | PF00069 | 0.400 | 
| MOD_Plk_4 | 49 | 55 | PF00069 | 0.524 | 
| MOD_Plk_4 | 82 | 88 | PF00069 | 0.461 | 
| MOD_ProDKin_1 | 233 | 239 | PF00069 | 0.584 | 
| MOD_ProDKin_1 | 76 | 82 | PF00069 | 0.390 | 
| MOD_SUMO_for_1 | 364 | 367 | PF00179 | 0.623 | 
| TRG_DiLeu_BaEn_1 | 248 | 253 | PF01217 | 0.400 | 
| TRG_ENDOCYTIC_2 | 227 | 230 | PF00928 | 0.538 | 
| TRG_ER_diArg_1 | 186 | 188 | PF00400 | 0.493 | 
| TRG_ER_diArg_1 | 222 | 225 | PF00400 | 0.360 | 
| TRG_ER_diArg_1 | 376 | 378 | PF00400 | 0.563 | 
| TRG_NLS_Bipartite_1 | 298 | 312 | PF00514 | 0.434 | 
| TRG_NLS_MonoExtC_3 | 360 | 365 | PF00514 | 0.639 | 
| TRG_NLS_MonoExtN_4 | 307 | 312 | PF00514 | 0.470 | 
| TRG_NLS_MonoExtN_4 | 361 | 366 | PF00514 | 0.635 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1I0U9 | Leptomonas seymouri | 57% | 77% | 
| A0A0S4JCB2 | Bodo saltans | 43% | 99% | 
| A0A1X0NY04 | Trypanosomatidae | 45% | 100% | 
| A0A3R7KMU3 | Trypanosoma rangeli | 48% | 100% | 
| A4HBR8 | Leishmania braziliensis | 83% | 100% | 
| A4HZ72 | Leishmania infantum | 99% | 100% | 
| D0A1G6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% | 
| E9AV39 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% | 
| Q4QCE2 | Leishmania major | 93% | 100% | 
| V5BIF1 | Trypanosoma cruzi | 46% | 100% |